Robert BeckerÂ
 biotechnology
vaxxas
Australia
Biography
Dr. Becker has been with MEDInstill since 2011, leading the company's business and corporate development efforts. He spent the prior six years at the biotechnology company VaxInnate as the company's Vice President of Business Development. Before his tenure at VaxInnate, he spent 15 years leading vaccine development programs at sanofi pasteur in roles of increasing responsibility, ultimately leaving as a Vice President of Corporate Development. With thirteen years of business development experience, he has expertise in identifying, assessing, negotiating and managing collaborative product development relationships with large pharmaceuticals, biotechnology companies, academic institutions, international zone companies and government agencies. Prior to his business responsibilities, he headed the immunology section and a vaccine development project at sanofi pasteur which addressed the development of vaccines for pneumococcal disease, influenza, JEV, Lyme's disease and pediatric combination vaccines. His academic experience included junior faculty positions at Loyola University Chicago and University of Illinois Chicago in the field of Immunology. Dr. Becker received his PhD from in Microbiology and Immunology from the University of Kansas and his MBA from Columbia University.
Research Interest
biotechnology